This document discusses how pharmacogenomic (PGx) testing can help medical practices safely and effectively treat patients by determining if medications will be ineffective or dangerous for a patient based on their genetic profile. It provides steps on how the nurse, doctor, and biller should handle PGx testing for eligible patients, which can increase reimbursement for the practice. PGx America offers a simplified process for practices to access this diagnostic tool without investment or additional staff workload, and will provide test results and support to help practitioners incorporate this technology.